Parkside Financial Bank & Trust - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 223 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.

Quarter-by-quarter ownership
Parkside Financial Bank & Trust ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$5,046
-0.1%
183
+8.9%
0.00%0.0%
Q2 2023$5,051
-17.0%
1680.0%0.00%
-50.0%
Q1 2023$6,087
+1.6%
1680.0%0.00%0.0%
Q4 2022$5,993
-0.1%
1680.0%0.00%0.0%
Q3 2022$6,000
+20.0%
1680.0%0.00%0.0%
Q2 2022$5,000
-16.7%
168
-2.3%
0.00%0.0%
Q1 2022$6,000
+20.0%
172
+2.4%
0.00%
+100.0%
Q4 2021$5,000
+25.0%
168
+2.4%
0.00%0.0%
Q3 2021$4,000
-33.3%
164
-8.9%
0.00%
-50.0%
Q2 2021$6,000
+50.0%
180
+9.8%
0.00%
+100.0%
Q1 2021$4,0000.0%1640.0%0.00%0.0%
Q4 2020$4,000
+300.0%
164
+485.7%
0.00%
Q3 2020$1,0000.0%28
-36.4%
0.00%
Q2 2020$1,00044
+100.0%
0.00%
Q1 2020$0
-100.0%
22
-71.4%
0.00%
-100.0%
Q4 2019$2,000
+100.0%
77
+60.4%
0.00%
Q3 2019$1,000
-50.0%
48
-11.1%
0.00%
-100.0%
Q1 2019$2,000
+100.0%
54
+25.6%
0.00%
Q4 2018$1,000
-50.0%
43
+26.5%
0.00%
-100.0%
Q3 2018$2,0000.0%340.0%0.00%0.0%
Q2 2018$2,000
+100.0%
34
+9.7%
0.00%
Q1 2018$1,0000.0%310.0%0.00%
Q4 2017$1,0000.0%310.0%0.00%
Q3 2017$1,0000.0%310.0%0.00%
Q2 2017$1,0000.0%310.0%0.00%
Q1 2017$1,0000.0%310.0%0.00%
Q4 2016$1,000310.00%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
ASHFORD CAPITAL MANAGEMENT INC 698,676$41,816,0005.51%
Provident Investment Management, Inc. 543,194$32,510,0004.61%
NEUMEIER POMA INVESTMENT COUNSEL LLC 426,250$25,511,0002.37%
KOPP INVESTMENT ADVISORS LLC 41,879$2,506,0002.35%
AlphaOne Investment Services, LLC 126,279$7,558,0002.17%
Ranger Investment Management 468,933$28,066,0001.96%
Bruce & Co., Inc. 158,058$9,459,0001.88%
Penserra Capital Management LLC 244,371$29,030,0001.83%
SHAKER INVESTMENTS LLC/OH 49,642$2,971,0001.83%
Bridge City Capital, LLC 47,795$2,861,0001.81%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders